Investors in Xiaomi will be hoping the company can leverage its proven ability to manufacture and market good value-for-money smartphone hardware into a sticky software ecosystem that will allow the ...

We view Pinterest as a differentiated player that has carved out a niche in a crowded digital advertising market. While the firm’s user count remains markedly below its larger social media peer Meta, ...

If Kennedy is confirmed, we may lower our US vaccine sales estimates, although we don’t think reductions would be ...

Alphabet Inc.'s Google is headed into an uncertain year, as regulators reportedly want a federal judge to force the company to sell off Chrome. But nothing is certain about this antitrust case.

Smartsheet is a leading provider of collaborative work management, or CWM, SaaS solutions. The emerging SaaS niche aims to improve the efficiency and productivity of project and process management by ...

The implications for stock investors are clear. You should not succumb to the hype and exuberance that typically accompanies M&A waves, in which both corporate America and the financial media are ...

Biotech-stock investing has one tough test for success - and it's about to get easier ...

Pressure builds on the Biden administration to process promised student-loan cancellations in its waning days Stephen Richards received a letter in May from the Biden administration promising to ...

No, the "Fed model" is not going to sabotage the stock market. I'm referring to the famous market-timing model that compares the stock market's earnings yield (the inverse of the price-to-earnings, or ...

The Education Department paused SAVE as the litigation worked its way through the court system. That means that borrowers enrolled in the plan don't have to make payments, but the months they spend in ...

Super Micro shares (SMCI) will remain listed pending the plan's review. The stock rallied about 40% in the extended session Monday after the news. The company also said that BDO USA has been named its ...

Here are 4 biotech stocks that could get a boost from a more open FDA regulatory climate The key to successful biotech investing is straightforward: Own stocks of companies that get drugs approved.